Understanding whether Parkinson’s disease is passed down through families is one of the most common concerns for individuals and their relatives. While every case of Parkinson’s involves genetics at a cellular level, only a small portion of cases are considered truly hereditary. For the vast majority of people, the condition occurs due to a complex interaction between genetic predisposition and environmental triggers. This distinction is vital for families to understand their own risk levels and the role that genetic testing might play in their healthcare journey.
What we will discuss in this article
- The distinction between genetic factors and hereditary inheritance
- Common gene mutations associated with Parkinson’s risk
- The percentage of cases that are considered sporadic versus familial
- How specific genes like LRRK2 and GBA1 influence the condition
- The role of family history in determining personal risk levels
- When genetic testing is recommended for patients and families
- Emergency guidance for acute neurological changes
The difference between genetic and hereditary
It is important to clarify that while Parkinson’s is a genetic condition in a broad sense, it is rarely a hereditary one in the traditional way.
All Parkinson’s involves genes because changes in DNA affect how brain cells function. However, the term hereditary refers to a specific gene mutation that is passed directly from a parent to a child, which then causes the disease. For about 85 to 90 percent of people, the disease is sporadic. This means it happens by chance, likely because the person was born with a combination of common genetic variations that made them slightly more susceptible to environmental factors like pesticides or pollution over time.
Common genes linked to Parkinson’s
Researchers have identified several key genes that can either directly cause Parkinson’s or significantly increase the risk of developing it.
GBA1 gene
The most common genetic risk factor is a variation in the GBA1 gene. Found in up to 10 percent of people with the condition, this variant does not always cause the disease. Instead, it increases the likelihood that a person will develop Parkinson’s as they age. People with a GBA1 variant may experience symptoms slightly earlier than those with the sporadic form.
LRRK2 gene
This gene is associated with approximately 1 percent of all cases. A mutation in LRRK2 is considered an autosomal dominant factor, meaning only one parent needs to pass the gene for the risk to exist. However, not everyone who inherits the LRRK2 mutation will go on to develop symptoms.
SNCA gene
This was the first gene identified as a direct cause of the condition. While mutations in SNCA are extremely rare, they lead to the overproduction or misfolding of alpha synuclein, the protein that forms Lewy bodies in the brain.
Inheritance patterns and family risk
If you have a close relative with Parkinson’s, your risk of developing the condition is slightly higher than that of the general population, but the overall probability remains low.
For the general public, the risk of developing Parkinson’s is about 1 percent. If you have a parent or sibling with the condition, that risk may rise to about 3 to 5 percent. In the rare cases where the disease is truly hereditary, it follows two main patterns:
- Autosomal dominant: One copy of the faulty gene from one parent is enough to increase the risk or cause the disease.
- Autosomal recessive: Two copies of the faulty gene, one from each parent, are required for the disease to manifest. This pattern is more common in early onset cases.
Early onset and genetic testing
The age at which symptoms first appear is often a strong indicator of a genetic link.
Individuals who are diagnosed before the age of 50 are much more likely to have a direct genetic cause, such as mutations in the PRKN or PINK1 genes. Because of this, clinical teams often prioritize genetic testing for younger patients or those with a very strong family history. Genetic testing can provide clarity for families, but it is a personal decision that should be discussed with a specialist. In many cases, knowing the genetic status does not currently change the standard treatment plan, though it can provide access to specific clinical trials focusing on gene targeted therapies.
Emergency guidance
While Parkinson’s is a slow process, sudden neurological changes should never be attributed to normal disease progression or genetics and require immediate assessment.
If you experience sudden and severe neurological changes, call 999 immediately.
Seek urgent medical help if you notice:
- Sudden and total inability to speak or a significant facial droop
- Rapid onset of confusion, delirium, or frightening hallucinations
- A severe fall that leads to a head injury or inability to get up
- Acute difficulty swallowing or a sudden change in breathing patterns
- Signs of a stroke such as sudden weakness in one arm or leg
To summarise
Parkinson’s disease is primarily a sporadic condition where genetics play a subtle role in increasing susceptibility. Only 10 to 15 percent of cases are considered hereditary, where a specific gene mutation is passed down within a family. For most people, the condition is the result of many small genetic factors combined with a lifetime of environmental exposures. While having a relative with the condition slightly increases your risk, it is by no means a guarantee of diagnosis. Understanding the difference between a genetic predisposition and a hereditary cause helps families make informed decisions about their health and future.
Does everyone with a Parkinson’s gene get the disease?
No. Many people carry risk genes like GBA1 or LRRK2 and never develop any symptoms. This is known as reduced penetrance, where other factors are needed to trigger the condition.
If my father has it, what are the chances I will get it?
For most people, the risk of developing the condition if a parent has it is roughly 3 to 5 percent. While higher than the general population, it still means there is a 95 percent or higher chance you will not develop it.
Can genetic testing predict when I might get symptoms?
Currently, genetic testing can only identify the presence of a mutation; it cannot predict exactly when or if symptoms will start.
Is early onset Parkinson’s always hereditary?
It is more likely to have a genetic basis than late onset disease, but it is not always hereditary. Some early cases are still sporadic.
Are there benefits to knowing my genetic status?
Knowing your status can help with family planning and may allow you to participate in research trials for new treatments targeting specific genes.
Can I prevent genetic Parkinson’s with a healthy lifestyle?
While you cannot change your genes, evidence suggests that regular exercise and a healthy diet can support brain health and may influence when symptoms appear.
How do I get a genetic test for Parkinson’s?
Testing is usually offered through a neurology specialist if you meet certain criteria, such as being diagnosed at a young age or having multiple affected relatives.
Authority Snapshot
This article was reviewed by Dr. Stefan Petrov, a UK trained physician with an MBBS and postgraduate certifications including Basic Life Support, Advanced Cardiac Life Support, and the UK Medical Licensing Assessment. He has hands on experience in general medicine, surgery, and emergency care. Dr. Petrov has worked in hospital wards and intensive care units, performing diagnostic and therapeutic procedures, and has contributed to medical education by creating patient focused health content and teaching clinical skills to junior doctors.
